Status:
UNKNOWN
The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients
Lead Sponsor:
Liu ZiMeng
Conditions:
Terlipressin
Septic Shock
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Terlipressin becomes a vasopressin for septic shock. But some studies found it may lead to severe intesitnal complications such as intestinal ischemia. The investigators study was designed to find the...
Eligibility Criteria
Inclusion
- septic shock
Exclusion
- shock due to other reasons
- diagnosited intesitinal ischemia
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02306239
Start Date
December 1 2014
Last Update
December 30 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Affiliated Hospital of Sumyetsan University
Guangzhou, Guangdong, China, 510080